ProPath, a Sonic Healthcare anatomic pathology practice, is privileged to include Jamie Koo, M.D., as a part of its dynamic medical staff. Dr. Koo is a board-certified pathologist who brings professional medical experience in both hospital and laboratory settings. 

Dr. Koo graduated with a bachelor’s degree in molecular and cell biology from the University of California, Berkeley, in Berkeley, CA. She earned her medical degree from the University of Texas Southwestern Medical School in Dallas. She served her residency in anatomic and clinical pathology at Cedars-Sinai Medical Center in Los Angeles, CA, where she held the position of chief resident. She then completed fellowships in genitourinary and surgical pathology and gastrointestinal and liver pathology at the University of California, Los Angeles. 

Dr. Koo started as a staff pathologist in the pathology and laboratory medicine department at Cedars-Sinai Medical Center in Los Angeles. While there, she held an appointment as an assistant professor of pathology, also at Cedars-Sinai Medical Center. She’s been a pathologist at ProPath in Dallas, Texas, since 2018. 

Dr. Koo has published a number of peer-reviewed manuscripts in journals such as Modern Pathology, JAMA Surgery, Endocrine Pathology, and Clinical Transplantation, among others. She has published book chapters in Practical Gastrointestinal Pathology, Practical Atlas of Transplant Pathology, and The Kidney: A Comprehensive Guide to Pathologic Diagnosis and Management. She has also published abstracts in journals such as Modern Pathology and presented them at meetings of the United States and Canadian Academy of Pathology and the North American NeuroEndocrine Tumor Society. 

Education

University of California, Berkeley (BA)
Berkeley, CA

University of Texas Southwestern Medical School (MD)
Dallas, TX

Postgraduate Training

Gastrointestinal and Liver Pathology Fellowship
University of California, Los Angeles
Los Angeles, CA

Genitourinary and Surgical Pathology Fellowship
University of California, Los Angeles
Los Angeles, CA

Anatomic and Clinical Pathology Residency
(Chief Resident)
Cedars-Sinai Medical Center
Los Angeles, CA

Professional Memberships

American Society for Clinical Pathology

College of American Pathologists

Rodger C. Haggitt Gastrointestinal Pathology Society

United States and Canadian Academy of Pathology

Peer-Reviewed Articles

1. Sirohi D, Vaske C, Sanborn Z, Smith SC, Don MD, Lindsey KG, Federman S, Vankalakunti M, Koo J, Bose S, Peralta-Venturina M, Ziffle JV, Grenert JP, Miller S, Chiu C, Amin MB, Simko JP, Stohr BA, Luthringer DJ. Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study.  Mod Pathol. 2018;31(9):1429-1441.
   
   
2. Williams JL, Chan CK, Toste PA, Elliot IA, Vasquez CR, Sunjaya DB, Swanson EA, Koo J, Hines OJ, Reber HA, Dawson DW, Donahue DR. Association of histopathologic phenotype of periampullary adenocarcinomas with survival. JAMA Surg. 2017;152(1):82-88.
   
   
3. Singhi AD, Ali SM, Lacy J, Hendifar A, Nguyen K, Koo J, Chung JH, Greenbowe J, Ross JS, Nikiforova MN, Zeh HJ, Sarkaria IS, Dasyam A, Bahary N. Identification of targetable ALK rearrangements in pancreatic ductal adenocarcinoma. J Natl Compr Cancer Netw. 2017;15(5):555-562.
   
   
4. Whitcomb E, Choi WT, Jerome KR, Cook L, Landis C, Ahn J, Te HS, Esfeh J, Hanouneh IA, Rayhill SC, Gibson W, Plesec T, Koo J, Wang HL, Hart J, Pai RK, Westerhoff M. Biopsy specimens from allograft liver contain histologic features of hepatitis C virus infection after virus eradication. Clin Gastroenterol Hepatol. 2017;15(8):1279-1285.
   
   
5. Tuli R, Lo S, Koo J, Pishvaian M, Bender RJ, Petricoin E, Brody J, Nissen N. Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma.  JCO Precis Oncol. 2017;Aug 7. doi:10.1200/PO.17.00016.
   
   
6. Koo J, Dawson DW, Dry S, French SW, Naini BV, Wang HL. Allograft biopsy findings in patients with small bowel transplantation. Clin Transplant. 2016;30(11):1433-1439.
   
   
7. Lai JP, Mertens RB, Mirocha J, Koo J, Venturina M, Chung F, Mendez AB, Kahn M, Dhall D. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors. Endocr Pathol. 2015;26(1):54-62.
   
   
8. Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D. The immunohistochemical expression of Islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocr Pathol. 2013;24(4):184-190.
   
   
9. Koo J, Mertens RB, Mirocha JM, Wang HL, Dhall D. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol. 2012;25(6):893-901.
   
   
10. Sijwali PS, Koo J, Singh N, Rosenthal PJ. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol Biochem Parasitol. 2006;150(1):96-106.
    
    

Reviews

1. Koo J, Wang HL. Acute, chronic, and humoral rejection: pathologic features under current immunosuppressive regimes. Surg Pathol Clin. 2018;11(2):431-452.
   
   
2. Wang HL, Kim CJ, Koo J, Zhou W, Choi E, Arcega R, Chen ZE, Wang H, Zhang L, Lin F. Practical immunohistochemistry in neoplastic pathology of the gastrointestinal tract, liver, biliary tract, and pancreas. Arch Pathol Lab Med. 2017;141(9):1155-1180.
   
   
3. Koo J, Dhall D. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy? Semin Diagn Pathol. 2015;32(6):456-468.
   
   

Book Chapters

1. Koo J, Wang HL. Transplant-related issues in the gastrointestinal tract. In: Wang HL, Chen ZE, eds. Practical Gastrointestinal Pathology. Cham, Switzerland: Springer; 2021:543-561. Practical Anatomic Pathology; vol 6.
   
   
2. Koo J, Wang H. Small bowel. In: Wallace W, Naini B, eds. Practical Atlas of Transplant Pathology. Switzerland: Springer; 2016:133-151.
   
   
3. Koo J, Filson C, Huang J, Pantuck A. Collecting duct carcinoma and renal medullary carcinoma. In: Hansel D, Kane C, Paner G, Chang S, eds. The Kidney: A Comprehensive Guide to Pathologic Diagnosis and Management. New York: Springer; 2016:106-123.
   
   

Abstracts

1. Sirohi D, Vaske C, Sanborn Z, Smith SC, Don MD, Lindsey KG, Federman S, Mahesha Vankalakunti M, Koo J, Bose S, de Peralta-Venturina M, van Ziffle J, Grenert JP, Miller S, Chiu C, Amin MB, Simko JP, Stohr BA, Luthringer DJ. BK viral integration in urologic malignancies [abstract 1079]. USCAP Meeting, 2018.  Mod Pathol. 2018;31(suppl 2s):386.
   
   
2. Don MD, Sirohi D, Smith SC, Vankalakunti M, Koo J, Bose S, de Peralta-Venturina M, Amin MB, Luthringer DJ. Polyoma virus-associated urologic malignancies in the immunocompromised setting: report of 8 cases [abstract 892]. USCAP Meeting, 2017. Mod Pathol. 2017;30(suppl 2s):221A.
   
   
3. Li Y, Verkouw K, Tabtabai S, Barrios R, Gill R, Koo J, Marboe C, Rodriguez E, Tan C, De Marco T, Estep J, Hanna M, Maurer MS, Patel J, Selby V, Semigran M, Stone J. Using gastrointestinal biopsy to predict outcome in patients evaluated for cardiac transplantation for amyloidosis: a report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT) [abstract]. Am J Transplant. 2016;16(suppl 3).
   
   
4. Williams JL, Chan C, Toste PA, Gawlas IA, Vasquez CR, Sunjaya DB, Swanson E, Koo J, Hines OJ, Reber HA, Dawson DW, Donahue TR. Periampullary cancers: histologic subtype is a stronger determinant of patient survival than anatomic location. Pacific Coast Surgical Association Meeting, Kohala Coast, HI, 2016.
   
   
5. Zhou W, Koo J, Chen ZE, Liu H, Lin F, Wang HL. Diagnostic utility of clusterin immunostaining in differentiating hepatocellular carcinoma from tumors of other origins [abstract 892]. USCAP Meeting, 2016. Mod Pathol. 2016;29(suppl 2s):428-429A.
   
   
6. Whitcomb E, Gibson W, Koo J, Landis C, Rayhill S, Ahn J, Hanouneh I, Esfeh J, Te H, Wang H, Hart J, Pai R, Westerhoff M. Allograft liver biopsies still show histologic features of recurrent HCV following sustained virologic response [platform, abstract 1700]. USCAP Meeting, 2015. Mod Pathol. 2015;28(suppl 2s):426A.
   
   
7. Swanson E, Toste PA, Koo J, Sunjaya DB, Vasquez CR, Donahue TR, Dawson DW. Pancreaticobiliary histologic phenotype is predictive of worse overall survival in ampullary carcinoma [abstract 771].
   USCAP Meeting, 2015. Mod Pathol. 2015;28(suppl 2s):194A.
   
   
8. Koo J, Dawson DW, Dry S, French SW, Naini B, Wang HL. Biopsy findings in patients withsmall bowel transplantation [abstract 754]. USCAP Meeting, 2014. Mod Pathol. 2014;27(suppl 2s):185A.
   
   
9. Zhou X, Dhall D, Moschiano E, Mertens RB, De Peralta-Venturina M, Koo J. The immunohistochemical expression of Islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
   North American NeuroEndocrine Tumor Society (NANETS) Meeting, 2014. 2014;43(3):509.
   
   
10. Lai JP, Koo J, Chung F, Mendez AB, Kahn M, Mertens R, Dhall D. Comparison of PAX6 and PAX8 as markers for pancreatic neuroendocrine tumors (NETs). USCAP Meeting, 2013. Mod Pathol. 2015;26(suppl 2s):427A.
    
    
11. Koo J, Moschiano E, Mertens R, Dhall D. Immunohistochemical staining of rectalneuroendocrine tumors overlaps with pancreatic neuroendocrine tumors [abstract 688]. USCAP Meeting, 2012. Mod Pathol. 2012;25(suppl 2s):166A.
    
    
12. Koo J, Mertens R, Dhall D. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrinetumors of pancreatic origin [platform presentation]. NANETS Meeting, 2012. 2012;41(2):339-340.
    
    
13. Koo J, Mertens R, Wang H, Dhall D. Value of Islet 1 and PAX8 in identifying metastaticneuroendocrine tumors of pancreatic origin [platform, abstract 576]. USCAP Meeting, 2011.  Mod Pathol. 2011;24(suppl 1s):138A.